The purpose of the Model Continuums of Care Initiative (MCCI) for Women and Girls at Risk and Living with HIV/AIDS and Harmful Alcohol and Associated Comorbidities Initiative is to promote the development and evaluation of integrated multilevel interventions to reduce alcohol consumption as a key approach to preventing new infections and enhancing treatment adherence in communities in the U.S. where racial and ethnic minority women bear a disproportionate share of the HIV/AIDS disease burden.
The purpose of this FOA is to encourage applications for research training programs to strengthen the scientific capacity of institutions in low- and middle-income countries (LMICs) to conduct HIV research relevant to the evolving HIV epidemic in their country.
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), announces the availability of one-year supplemental funding to enable grantees from the Targeted Capacity Expansion: Substance Abuse Treatment for Racial/Ethnic Minority Women at High Risk for HIV/AIDS Minority Women (TCE-HIV: Minority Women) cohort funded in FY 2014 to expand/enhance grant activities required under the Request for Application (RFA), TI-13-011.
The Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, is accepting applications for fiscal year (FY) 2016 Targeted Capacity Expansion HIV: Substance Use Disorder Treatment for Racial/Ethnic Minority Women at High-Risk for HIV/AIDS (TCE-HIV: Minority Women) grants.
This FOA will support one-year, services planning research grants to develop anepidemiologic understanding of opioid injection drug use, Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) infection risk, and other adverse health consequences of such drug use, in conjunction with determining what resources/programs are currently available for addressing those problems, in any of the 420 Appalachian counties (www.arc.gov/counties).
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for a fiscal year (FY) 2016 Cooperative Agreement to Support the Establishment of a Ukraine HIV International Addiction Technology Transfer Center (UHATTC) (Short Title: Ukraine International HIV ATTC ).
The purpose of this FOA is to encourage investigators to propose discrete well-defined projects that can be completed within three years. Projects of interest fall within the research domain of behavioral or integrated (e.g., behavioral and pharmacological) interventions targeting: (a) substance abuse; (b) prevention of acquisition or transmission of HIV infection among individuals in substance abuse treatment; (c) promotion of adherence to substance abuse treatment, HIV and addiction medications; and (d) chronic pain.
The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) is accepting applications for a fiscal year (FY) 2016 Cooperative Agreement to Support the Establishment of a Southeast (SE) Asia Regional HIV Addiction Technology Transfer Center (ATTC) (Short Title: SE Asia Regional HIV ATTC).
This announcement solicits applications for the Ryan White HIV/AIDS Program (RWHAP) Part A HIV Emergency Relief Grant Program. Part A funds provide direct financial assistance to an eligible metropolitan area (EMA) or a transitional grant area (TGA) that has been severely affected by the HIV epidemic. Grants assist eligible program areas in developing or enhancing access to a comprehensive continuum of high quality, community-based care for low-income individuals and families with HIV through the provision of formula, supplemental, and Minority AIDS Initiative (MAI) funds.
This FOA provides resources to support (a) pilot or feasibility studies of new or adapted interventions to prevent HIV infection among populations where substance use may be a contributing factor; (b) pilot or feasibility studies of new or adapted interventions to improve the care of HIV infection among populations where substance use is prevalent, including interventions that integrate treatment for substance use disorders and HIV infection; or (c) pilot or feasibility studies to increase the scale, uptake, delivery, and/or quality of HIV prevention or care interventions with established e